Revaxis inj. susp. i.m. pre-filled syr.

Land: Belgien

Sprog: engelsk

Kilde: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktiv bestanddel:

Poliovirus Type 2 (inactivated) 8 D-antigen U; Tetanus Toxoid >= 20 IU/dose; Diphtheria Toxoid (DT) >= 2 IU/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U; Poliovirus Type 3 (inactivated) 32 D-antigen U

Tilgængelig fra:

Sanofi Pasteur Europe S.A.

ATC-kode:

J07CA01

INN (International Name):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed

Lægemiddelform:

Suspension for injection

Sammensætning:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed

Indgivelsesvej:

Intramuscular use

Terapeutisk område:

Diphtheria-Poliomyelitis-Tetanus

Produkt oversigt:

CTI code: 207873-01 - Pack size: 0.5 ml - Commercialisation status: YES - FMD code: 03664798005189 - CNK code: 2231900 - Delivery mode: Medical prescription; CTI code: 207873-03 - Pack size: 20 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 207873-02 - Pack size: 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Autorisation status:

Commercialised: Yes

Autorisation dato:

1999-12-13